Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3

M. Andrew Nesbit, Fadil M. Hannan, Sarah A. Howles, Anita A.C. Reed, Treena Cranston, Clare E. Thakker, Lorna Gregory, Andrew J. Rimmer, Nigel Rust, Una Graham, Patrick J. Morrison, Steven J. Hunter, Michael P. Whyte, Gil Mcvean, David Buck, Rajesh V. Thakker

Research output: Contribution to journalArticlepeer-review

229 Scopus citations

Abstract

Adaptor protein-2 (AP2), a central component of clathrin-coated vesicles (CCVs), is pivotal in clathrin-mediated endocytosis, which internalizes plasma membrane constituents such as G protein-coupled receptors (GPCRs). AP2, a heterotetramer of α, β, μ and σ subunits, links clathrin to vesicle membranes and binds to tyrosine- and dileucine-based motifs of membrane-associated cargo proteins. Here we show that missense mutations of AP2 σ subunit (AP2S1) affecting Arg15, which forms key contacts with dileucine-based motifs of CCV cargo proteins, result in familial hypocalciuric hypercalcemia type 3 (FHH3), an extracellular calcium homeostasis disorder affecting the parathyroids, kidneys and bone. We found AP2S1 mutations in >20% of cases of FHH without mutations in calcium-sensing GPCR (CASR), which cause FHH1. AP2S1 mutations decreased the sensitivity of CaSR-expressing cells to extracellular calcium and reduced CaSR endocytosis, probably through loss of interaction with a C-terminal CaSR dileucine-based motif, whose disruption also decreased intracellular signaling. Thus, our results identify a new role for AP2 in extracellular calcium homeostasis.

Original languageEnglish
Pages (from-to)93-97
Number of pages5
JournalNature Genetics
Volume45
Issue number1
DOIs
StatePublished - Jan 2013

Fingerprint

Dive into the research topics of 'Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3'. Together they form a unique fingerprint.

Cite this